Related Experiment Video

Updated: May 4, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

[Integration to school of young children with type 1 diabetes on insulin pump therapy: parent's feed-back]

H Crosnier1, N Tubiana-Rufi2

  • 1Service de pédiatrie, centre hospitalier intercommunal de Poissy-Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78300 Poissy, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|December 24, 2013
PubMed

Insights

Continuous subcutaneous insulin infusion (CSII) is popular for young children with type 1 diabetes (T1D). While parental satisfaction is high, managing T1D in school settings presents significant challenges that require improvement.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Diabetes Management

Context:

  • Increasing incidence of type 1 diabetes (T1D) in children under 5.
  • Growing popularity of continuous subcutaneous insulin infusion (CSII) for pediatric T1D in France.
  • Need to assess T1D management in non-parental care settings.

Purpose:

  • To evaluate the quality of diabetes management for young children with T1D using CSII in daycare and school settings.
  • To identify challenges faced by parents and children in these environments.
  • To assess parental satisfaction with current T1D care outside the home.

Summary:

  • A retrospective questionnaire surveyed parents of 42 children (mean age 4.8 years) on CSII for T1D.
  • Most parents reported good overall satisfaction but faced significant difficulties (e.g., exclusion, pump use, glucose monitoring).
  • Despite challenges, children generally had safe school experiences, highlighting the need for improved support and education for caregivers.

Impact:

  • Highlights the need for better training and support systems for daycare staff and teachers managing T1D.
  • Suggests that improved caregiver education can lead to more positive and inclusive experiences for children with T1D.
  • Informs strategies to enhance the safety and quality of life for young children with T1D in educational and care settings.

More Related Videos

Control of Eating Behavior Using a Novel Feedback System04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.9K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.7K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
43.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.2K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26